Rameshwar S. Cheke

771 total citations
23 papers, 564 citations indexed

About

Rameshwar S. Cheke is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Rameshwar S. Cheke has authored 23 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Organic Chemistry and 6 papers in Infectious Diseases. Recurrent topics in Rameshwar S. Cheke's work include Computational Drug Discovery Methods (6 papers), Diverse Scientific Research Studies (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Rameshwar S. Cheke is often cited by papers focused on Computational Drug Discovery Methods (6 papers), Diverse Scientific Research Studies (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Rameshwar S. Cheke collaborates with scholars based in India, Malaysia and Indonesia. Rameshwar S. Cheke's co-authors include Sachin D. Shinde, Vaishali M. Patil, Sandip D. Firke, Sanjay B. Bari, Prashant S. Kharkar, Iqrar Ahmad, Adel Kadri, Harun Patel, Visweswara Rao Pasupuleti and Mejdi Snoussi and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Omega and Journal of Molecular Structure.

In The Last Decade

Rameshwar S. Cheke

20 papers receiving 543 citations

Peers

Rameshwar S. Cheke

CTM

PHARM

Salima Lalani Malaysia

Gowramma Byran India

Neelutpal Gogoi India

Sachin D. Shinde India

Muhammad Khattab Egypt

Vishnu Nayak Badavath India

Khalil El Khatabi Morocco

Khattab Al-Khafaji Türkiye

Maywan Hariono Indonesia

Sajda Ashraf Pakistan

Salima Lalani Malaysia

Rameshwar S. Cheke

271 ×1.2

207 ×1.1

88 ×0.6

CTM

55 ×0.7

67 ×1.1

PHARM

Citations per year, relative to Rameshwar S. Cheke Rameshwar S. Cheke (= 1×) peers Salima Lalani

Countries citing papers authored by Rameshwar S. Cheke

Since Specialization

Citations

This map shows the geographic impact of Rameshwar S. Cheke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rameshwar S. Cheke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rameshwar S. Cheke more than expected).

Fields of papers citing papers by Rameshwar S. Cheke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rameshwar S. Cheke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rameshwar S. Cheke. The network helps show where Rameshwar S. Cheke may publish in the future.

Co-authorship network of co-authors of Rameshwar S. Cheke

This figure shows the co-authorship network connecting the top 25 collaborators of Rameshwar S. Cheke. A scholar is included among the top collaborators of Rameshwar S. Cheke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rameshwar S. Cheke. Rameshwar S. Cheke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheke, Rameshwar S. & Prashant S. Kharkar. (2023). Covalent inhibitors: An ambitious approach for the discovery of newer oncotherapeutics. Drug Development Research. 85(1). e22132–e22132. 14 indexed citations

Cheke, Rameshwar S., Vaishali M. Patil, Sandip D. Firke, et al.. (2022). Therapeutic Outcomes of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in Drug Discovery. Pharmaceuticals. 15(3). 272–272. 83 indexed citations

Cheke, Rameshwar S., Harun Patel, Vaishali M. Patil, et al.. (2022). Molecular Insights into Coumarin Analogues as Antimicrobial Agents: Recent Developments in Drug Discovery. Antibiotics. 11(5). 566–566. 51 indexed citations

Bari, Sanjay B., Sanjay J. Surana, Atul A. Shirkhedkar, et al.. (2022). Discovery and Anticancer Activity of Novel 1,3,4-Thiadiazole- and Aziridine-Based Indolin-2-ones via In Silico Design Followed by Supramolecular Green Synthesis. ACS Omega. 7(20). 17270–17294. 20 indexed citations

Verma, Saroj, Neeraj Masand, Rameshwar S. Cheke, & Vaishali M. Patil. (2022). Protein Informatics and Vaccine Development: Cancer Case Study. Current Topics in Medicinal Chemistry. 22(26). 2207–2220.

Cheke, Rameshwar S., et al.. (2021). Understanding the Dynamics of COVID-19 Outbreak: Structure, Diagnosis, Prevention and Treatment. Anti-Infective Agents. 19(4).

Cheke, Rameshwar S., et al.. (2021). Recent advances in pharmacological diversification of Src family kinase inhibitors. SHILAP Revista de lepidopterología. 22(1). 15 indexed citations

Shinde, Sachin D., et al.. (2021). Abrogation of cisplatin-induced nephrotoxicity in rats and HEK-293 cell lines by formononetin: in vivo and in vitro study. Comparative Clinical Pathology. 30(4). 617–625. 8 indexed citations

Cheke, Rameshwar S., et al.. (2021). A Concise Analytical Profile of Efavirenz: Analytical Methodologies. Critical Reviews in Analytical Chemistry. 52(7). 1583–1592. 11 indexed citations

10.

Cheke, Rameshwar S., et al.. (2021). Futuristic review on progress in force degradation studies and stability indicating assay method for some antiviral drugs. Zenodo (CERN European Organization for Nuclear Research). 1 indexed citations

11.

Cheke, Rameshwar S., et al.. (2021). Quinazoline: An update on current status against convulsions. Journal of Molecular Structure. 1248. 131384–131384. 27 indexed citations

12.

Cheke, Rameshwar S., et al.. (2021). Futuristic review on progress in force degradation studies and stability indicating assay method for some antiviral drugs. GSC Biological and Pharmaceutical Sciences. 16(1). 133–149. 7 indexed citations

13.

Cheke, Rameshwar S., et al.. (2020). Natural Product Emerging as Potential SARS Spike Glycoproteins-ACE2 Inhibitors to Combat COVID-19 Attributed by In-Silico Investigations. Biointerface Research in Applied Chemistry. 11(3). 10628–10639. 10 indexed citations

14.

Cheke, Rameshwar S., et al.. (2020). Repurposing of Anthelmintic Drugs against SARS-CoV-2 (Mpro and RdRp): Novel Disease, Older Therapeutics. Letters in Applied NanoBioScience. 10(2). 2331–2338. 2 indexed citations

15.

Cheke, Rameshwar S., et al.. (2020). Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences. Natural Products and Bioprospecting. 10(5). 297–306. 160 indexed citations

16.

Shinde, Sachin D., et al.. (2020). The Berberis aristata Ameliorates oxazolone induced contact dermatitis: in-vivo and in silico evidences. Advances in Traditional Medicine. 21(4). 685–692. 8 indexed citations

17.

Cheke, Rameshwar S.. (2020). The Molecular Docking Study of Potential Drug Candidates Showing Anti-COVID-19 Activity by Exploring of Therapeutic Targets of SARS-CoV-2. Eurasian Journal of Medicine and Oncology. 80 indexed citations

18.

Patil, Vaishali M., et al.. (2020). Molecular Insights into Resveratrol and Its Analogs as SARS-CoV-2 (COVID-19) Protease Inhibitors. Coronaviruses. 2(11). 10–27. 7 indexed citations

19.

Cheke, Rameshwar S., et al.. (2020). Coronavirus: Hotspot on coronavirus disease 2019 in India. Indian Journal of Medical Sciences. 72. 29–34. 12 indexed citations

20.

Cheke, Rameshwar S., et al.. (2018). ISATIN: New Hope Against Convulsion. Central Nervous System Agents in Medicinal Chemistry. 18(2). 76–101. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact